% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Rattay:165985,
author = {T. Rattay and P. Seibold$^*$ and M. E. Aguado-Barrera and
M. Altabas and D. Azria and G. C. Barnett and R. Bultijnck
and J. Chang-Claude$^*$ and A. Choudhury and C. E. Coles and
A. M. Dunning and R. M. Elliott and M.-P. Farcy Jacquet and
S. Gutiérrez-Enríquez and K. Johnson and A. Müller$^*$
and G. Post and T. Rancati and V. Reyes and B. S. Rosenstein
and D. De Ruysscher and M. C. de Santis and E. Sperk and H.
Stobart and R. P. Symonds and B. Taboada-Valladares and A.
Vega and L. Veldeman and A. J. Webb and C. M. West and R.
Valdagni and C. J. Talbot and Y. Lievens and M. van Eijkeren
and P. Ost and V. Fonteyne and C. Monten and W. De Neve and
S. Peeters and K. Haustermans and C. Weltens and G. Defraene
and M. Lambrecht and E. van Limberghen and E. Briers and C.
Bourgier and M. Brengues and R. Draghici and F. Bons and T.
Blaschke and C. Weiß and I. Helmbold and C. Weißenberger
and P. Stegmaier and J. Claßen and U. Giesche and M.-L.
Sautter-Bihl and B. Neu and T. Schnabel and M. Ehmann and B.
Gauter-Fleckenstein and C. Herskind and M. Veldwijk and J.
Schäfer and T. Giandini and M. Franceschini and C. Sangalli
and B. Avuzzi and S. Morlino and L. Lozza and G. Pietro and
E. Delmastro and E. Garibaldi and A. Cicchetti and B.
Vanneste and B. Piqué-Leiva and M. Molla and A. Giraldo and
M. Ramos and R. Lobato-Busto and P. Sosa-Fajardo and L. T.
Moya and I. Dominguez-Rios and I. Fajardo-Paneque and P.
Calvo-Crespo and A. Carballo and P. Peleteiro and
Olivia-Fuentes-Rios and A. Gomez-Caamano and V. Harrop and
D. Payne and M. Keni and S. Lavers and S. Wright and S.
Thiagarajan and L. Aznar-Garcia and K. Kancherla and C. Kent
and S. Vasanthan and D. Appleton and M. Kaushik and F. Kenny
and H. Khout and J. Krupa and K. V. Lambert and S. Pilgrim
and S. Shokuhi and K. Valassiadou and I. Bioangiu and K.
Sampson and A. Osman and C. Faivre-Finn and K. Foweraker and
A. Pascoe and C. P. Esler and T. Ward and D. S. Higginson
and R. G. Stock and S. Green},
collaboration = {R. consortium},
title = {{E}xternal {V}alidation of a {P}redictive {M}odel for
{A}cute {S}kin {R}adiation {T}oxicity in the {REQUITE}
{B}reast {C}ohort.},
journal = {Frontiers in oncology},
volume = {10},
issn = {2234-943X},
address = {Lausanne},
publisher = {Frontiers Media},
reportid = {DKFZ-2020-02524},
pages = {575909},
year = {2020},
abstract = {Background: Acute skin toxicity is a common and usually
transient side-effect of breast radiotherapy although, if
sufficiently severe, it can affect breast cosmesis,
aftercare costs and the patient's quality-of-life. The aim
of this study was to develop predictive models for acute
skin toxicity using published risk factors and externally
validate the models in patients recruited into the
prospective multi-center REQUITE (validating pREdictive
models and biomarkers of radiotherapy toxicity to reduce
side-effects and improve QUalITy of lifE in cancer
survivors) study. Methods: Patient and treatment-related
risk factors significantly associated with acute breast
radiation toxicity on multivariate analysis were identified
in the literature. These predictors were used to develop
risk models for acute erythema and acute desquamation (skin
loss) in three Radiogenomics Consortium cohorts of patients
treated by breast-conserving surgery and whole breast
external beam radiotherapy (n = 2,031). The models were
externally validated in the REQUITE breast cancer cohort (n
= 2,057). Results: The final risk model for acute erythema
included BMI, breast size, hypo-fractionation, boost,
tamoxifen use and smoking status. This model was validated
in REQUITE with moderate discrimination (AUC 0.65),
calibration and agreement between predicted and observed
toxicity (Brier score 0.17). The risk model for acute
desquamation, excluding the predictor tamoxifen use, failed
to validate in the REQUITE cohort. Conclusions: While most
published prediction research in the field has focused on
model development, this study reports successful external
validation of a predictive model using clinical risk factors
for acute erythema following radiotherapy after
breast-conserving surgery. This model retained
discriminatory power but will benefit from further
re-calibration. A similar model to predict acute
desquamation failed to validate in the REQUITE cohort.
Future improvements and more accurate predictions are
expected through the addition of genetic markers and
application of other modeling and machine learning
techniques.},
cin = {C020},
ddc = {610},
cid = {I:(DE-He78)C020-20160331},
pnm = {313 - Cancer risk factors and prevention (POF3-313)},
pid = {G:(DE-HGF)POF3-313},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:33216838},
pmc = {pmc:PMC7664984},
doi = {10.3389/fonc.2020.575909},
url = {https://inrepo02.dkfz.de/record/165985},
}